Brief: Starpharma Posts HY Revenue From Continuing Operations A$1.6 Million
28/02/2023 01:37
Feb 28 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1.6
MILLION
* HY LOSS FROM CONTINUING OPERATIONS ATTRIBUTABLE A$8.3
MILLION
VERSUS LOSS A$8.4 MILLION
Source text for Eikon: ID:nASX6y4WJr
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising